Label Changes for:
Atacand (Candesartan Cilexetil) Tablets
Changes have been made to the CONTRAINDICATIONS, WARNINGS, PRECAUTIONS and ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2013
- Atacand is contraindicated in patients who are hypersensitive to candesartan. Do not administer Aliskiren with Atacand in patients with diabetes.